When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
royaltystockphoto/iStock via Getty Images Aptorum Group ("APM") has announced additional positive phase 1 results for ALS-4, its candidate for Staphylococcus aureus. The new data for two additional cohorts shows that the drug was safe, well tolerated, with no serious adverse event. ALS-4 is a first-in-class oral drug using an anti-virulence approach. Apotorum plans to continue the phase 1 trial with a mass ascending dose trial this quarter.